{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:50Z","timestamp":1792823990885,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218900","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:45:49Z","timestamp":1792230349000},"page":"218900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["2-Hydroxyisobutyrylation of SRSF9 regulates CD44 alternative splicing to promote colorectal cancer liver metastasis"],"prefix":"10.1016","volume":"661","author":[{"given":"Mengrou","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huolian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218900_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218900_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13046-023-02729-7","article-title":"Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218900_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2026.218900_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12672-025-01976-8","article-title":"Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases","volume":"16","author":"Kuang","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.canlet.2026.218900_bib5","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.3390\/cancers15153835","article-title":"Transcriptomic maps of colorectal liver metastasis: machine learning of gene activation patterns and epigenetic trajectories in support of precision medicine","volume":"15","author":"Ashekyan","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218900_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101097","article-title":"Pathological implication of protein post-translational modifications in cancer","volume":"86","author":"Pan","year":"2022","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.canlet.2026.218900_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/mco.2025.2834","article-title":"Histone crotonylation in tumors","volume":"22","author":"Wang","year":"2025","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218900_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2026.218900_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nchembio.1497","article-title":"Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark","volume":"10","author":"Dai","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218900_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","article-title":"Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner","volume":"33","author":"Xiao","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218900_bib11","article-title":"Lysine 2-hydroxyisobutyrylation- and succinylation-based pathways act inside chloroplasts to modulate plant photosynthesis and immunity","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218900_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbrc.2021.04.083","article-title":"Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells","volume":"560","author":"Yuan","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218900_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1758","article-title":"Alternative splicing: an efficient regulatory approach towards plant developmental plasticity","volume":"14","author":"Muhammad","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.canlet.2026.218900_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","article-title":"Alternative splicing and cancer: a systematic review","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218900_bib15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41419-021-04031-w","article-title":"Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218900_bib16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1101\/gad.1934910","article-title":"A rational nomenclature for serine\/arginine-rich protein splicing factors (SR proteins)","volume":"24","author":"Manley","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218900_bib17","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/0008-5472.CAN-24-4233","article-title":"SRSF9 forms phase-separated condensates to promote ovarian cancer progression by inducing RNA alternative splicing that is inhibited by m6A modification","volume":"85","author":"Guo","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218900_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jare.2025.03.013","article-title":"SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid-liquid phase separation to promote oral cancer progression","volume":"79","author":"Peng","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.canlet.2026.218900_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12967-022-03399-3","article-title":"SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner","volume":"20","author":"Wang","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218900_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218900_bib21","doi-asserted-by":"crossref","first-page":"12235","DOI":"10.1016\/S0021-9258(18)31376-0","article-title":"The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat","volume":"268","author":"Screaton","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218900_bib22","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jcmm.17221","article-title":"siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition","volume":"26","author":"Zou","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2026.218900_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.20892\/j.issn.2095-3941.2020.0495","article-title":"CD44V8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells","volume":"18","author":"Fontanella","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2026.218900_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.614281","article-title":"Overexpression of CD44V8-10 in colon polyps-a possible key to early diagnosis","volume":"27","author":"Dastych","year":"2021","journal-title":"Pathol. Oncol. Res."},{"issue":"14","key":"10.1016\/j.canlet.2026.218900_bib25","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.scib.2026.04.015","article-title":"tRF-Glu-TTC-013 promotes colorectal cancer liver metastasis through a CREB3L1-AMDHD1 metabolic axis","volume":"71","author":"Li","year":"2026","journal-title":"Sci. Bull.,"},{"key":"10.1016\/j.canlet.2026.218900_bib26","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.ajpath.2025.06.013","article-title":"NSUN5 mediates resistance to doxorubicin via up-regulation of DNA damage repair proteins BRCA2 and BRIP1 in colorectal cancer","volume":"195","author":"Xu","year":"2025","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218900_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31435","article-title":"Research advances in protein lysine 2-hydroxyisobutyrylation: from mechanistic regulation to disease relevance","volume":"239","author":"Huang","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218900_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/procel\/pwaf092","article-title":"Lipid deposition promotes YTHDF3-mediated m6A modification of PPAR\u03b1 to facilitate liver metastasis of colorectal cancer","volume":"17","author":"Ni","year":"2026","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2026.218900_bib29","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.canlet.2026.218900_bib30","article-title":"Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer","volume":"1878","author":"He","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218900_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trecan.2020.04.011","article-title":"RNA splicing and cancer","volume":"6","author":"Wang","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218900_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s43018-022-00384-z","article-title":"Dysregulation and therapeutic targeting of RNA splicing in cancer","volume":"3","author":"Stanley","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218900_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom15060789","article-title":"Alternative splicing in tumorigenesis and cancer therapy","volume":"15","author":"Chen","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218900_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/ijc.35039","article-title":"EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis","volume":"155","author":"Wang","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218900_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.sbi.2008.11.004","article-title":"Catalysis and substrate selection by histone\/protein lysine acetyltransferases","volume":"18","author":"Berndsen","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.canlet.2026.218900_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins","volume":"460","author":"Finkel","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218900_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2195363","article-title":"The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development","volume":"24","author":"Boman","year":"2023","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2026.218900_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/cancers18010021","article-title":"Association of a CD44s-v5-v6 null phenotype with advanced stage cholangiocarcinoma: a preliminary study","volume":"18","author":"Myint","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218900_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/cells15050411","article-title":"Immune cell-specific and isoform-selective regulation of CD44 in pancreatic ductal adenocarcinoma links lymph node variant loss and exosomal CD44 to clinical outcome in pancreatic ductal adenocarcinoma","volume":"15","author":"Karabiber","year":"2026","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.canlet.2026.218900_bib40","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/cells14231873","article-title":"Therapeutic potential of an Anti-CD44v6 monoclonal antibody in xenograft models of colorectal and gastric cancer","volume":"14","author":"Nakamura","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218900_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","article-title":"Systematic and quantitative assessment of the ubiquitin-modified proteome","volume":"44","author":"Kim","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2026.218900_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ncb3358","article-title":"The increasing complexity of the ubiquitin code","volume":"18","author":"Yau","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218900_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt.3948","article-title":"Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides","volume":"35","author":"Iwamoto","year":"2017","journal-title":"Nat. Biotechnol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:25:59Z","timestamp":1792823159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":43,"alternative-id":["S0304383526006646"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218900","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-Hydroxyisobutyrylation of SRSF9 regulates CD44 alternative splicing to promote colorectal cancer liver metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218900"}}